49 results on '"Amariglio, Rebecca E"'
Search Results
2. Defining and characterizing neocortical tau resistance in preclinical Alzheimer’s Disease
3. Comparing the effectiveness of a brief observational study protocol versus a telephone call for Alzheimer’s disease prevention trial prescreening
4. Predicting change in depressive symptoms using longitudinal regional amyloid and cognition in cognitively unimpaired older adults
5. Self‐appraisal of cognitive performance in repeated daily digital assessments with amyloid and tau‐PET
6. Decline in everyday functioning in relation to cerebral tau burden across the clinical spectrum of Alzheimer’s disease
7. A brief questionnaire of self‐reported cognitive decline predicts MMSE and study partner QDRS: findings from the Davis Memory and Aging Cohort at Mass General Brigham
8. Parental history of memory impairment predicts β‐amyloid burden and positivity in a preclinical population
9. Sex differences in plasma p‐tau181 accumulation is associated with subsequent tau‐PET signal
10. Associations among depressive symptoms, hippocampal volume and cognition in community‐dwelling older Latinos
11. Evaluating depressive symptoms and risk of cognitive decline using longitudinal electronic health records
12. Longitudinal multi‐day learning curves (MDLCs) to capture subtle cognitive changes in preclinical Alzheimer’s disease
13. Impact of Stress, Loneliness and Sociodemographic Factors on Psychological Well‐Being During the COVID‐19 Pandemic
14. Associations between self and study partner report on the CFI with regional tau in a multi‐cohort study
15. The Mobile Toolbox for assessing cognition in older adults: associations with standardized cognitive testing and amyloid and tau PET
16. Systemic vascular risk, white matter injury, and relative cerebral blood flow independently contribute to cognitive decline beyond amyloid and tau burden
17. Examining the influence of changes in amyloid burden on both contemporaneous and subsequent cognitive decline: using a latent change score approach
18. Examining the influence of changes in amyloid burden on both contemporaneous and subsequent cognitive decline: using a latent change score approach
19. Parental history of memory impairment predicts β‐amyloid burden and positivity in a preclinical population
20. Estimating a clinically normal individual’s position along a preclinical Alzheimer’s disease continuum using cognitive and amyloid trajectories
21. Early detection of amyloid‐related changes in memory among cognitively unimpaired older adults with daily digital testing
22. Subjective cognitive decline across ethnoracial groups in the A4 study
23. Using a digital assessment of multi‐day learning curves to detect preclinical AD
24. Association of Apathy with Amyloid‐β and Tau in Cognitively Unimpaired Older Adults: Findings from the Harvard Aging Brain Study
25. Boston Remote Assessment for Neurocognitive Health in preclinical AD
26. Assessing everyday functioning using a novel smartphone app in cognitively normal adults: A pilot study of the Assessment of Smartphone Everyday Tasks (ASSET)
27. Evaluation of ethnoracial differences in self‐ and study partner‐reported subjective cognitive decline in the A4 Study screen data
28. Fluctuations in reaction time performance as a marker of incipient amyloid‐related cognitive decline in clinically unimpaired older adults.
29. A longitudinal analysis of depressive symptoms in relation to repeated measurements of regional tau
30. A longitudinal analysis of depressive symptoms in relation to repeated measurements of regional tau
31. Multimodal neuroimaging biomarkers of Alzheimer’s disease in older adults with depression: Preliminary findings from a pilot cohort
32. Associations between remote cognitive testing on an individual’s own digital device and amyloid burden on neuroimaging in clinically normal older adults: Results from Boston Remote Assessment for Neurocognitive Health (BRANCH)
33. Resilience and perceived stress in cognitively normal older adults during the COVID‐19 pandemic
34. Association between the Harvard automated phone task and Alzheimer’s disease pathology in clinically normal older adults
35. The impact of COVID‐19 on the well‐being and cognition of older adults living in the United States and Latin America
36. Associations between biomarker status (amyloid, tau) and risk for progression to MCI/Dementia in the Harvard Aging Brain Study
37. Monthly computerized at‐home assessments to detect cognitive change in preclinical Alzheimer’s disease
38. Greater psychological resilience during the COVID‐19 pandemic is associated with lower tau burden in cognitively unimpaired individuals
39. Longitudinal trajectories of remote assessment of self‐ and study partner‐rated cognitive concerns, mood and Alzheimer’s disease biomarkers
40. Cortical microstructure is associated with tau burden and predicts cognitive decline and clinical progression in healthy older adults
41. Trajectories of self‐rated concerns in individuals developing cognitive decline
42. Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
43. Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system
44. Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline
45. Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
46. Using subjective cognitive decline to identify high global amyloid in community‐based samples: A cross‐cohort study
47. The impact of Aβ and tau on prospective cognitive decline in older individuals
48. Amyloid‐associated increases in longitudinal report of subjective cognitive complaints
49. Subjective cognitive concerns, episodic memory, and the APOE ε4 allele
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.